SCHEMBL834586

SCHEMBL834586

Cc1ccccc1NS(=O)(=O)c1ccc(-c2ccc(S(=O)(=O)Nc3ccccc3C)cc2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.75
KEAP1 Q14145 1/20 0.71
TSHR P16473 1/20 0.64
MEN1 O00255 4/20 0.60
KMT2A Q03164 4/20 0.60
MAPT P10636 2/20 0.60
GAA P10253 2/20 0.60
MAPK1 P28482 2/20 0.60
HTT P42858 1/20 0.60
RECQL P46063 1/20 0.60
LMNA P02545 3/20 0.59
L3MBTL1 Q9Y468 2/20 0.59
USP2 O75604 1/20 0.59
POLB P06746 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
NOD2 Q9HC29 1/20 0.59
HDAC4 P56524 1/20 0.58
HDAC6 Q9UBN7 1/20 0.58
CA12 O43570 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31681420 0.96 ALDH1A1 (0.71) ALDH1A1KEAP1TSHRMEN1KMT2A
SCHEMBL4623054 0.89 ALDH1A1 (0.75) ALDH1A1KEAP1TSHRMEN1KMT2A
SCHEMBL1116405 0.89 ALDH1A1 (0.74) ALDH1A1KEAP1TSHRMEN1KMT2A
SCHEMBL30102910 0.89 ALDH1A1 (0.74) ALDH1A1KEAP1TSHRMEN1KMT2A
SCHEMBL23057258 0.87 ALDH1A1 (0.73) ALDH1A1KEAP1TSHRMEN1KMT2A
SCHEMBL3081594 0.86 ALDH1A1 (0.71) ALDH1A1KEAP1TSHRMEN1KMT2A
SCHEMBL13875339 0.86 ALDH1A1 (0.71) ALDH1A1KEAP1TSHRMEN1KMT2A
SCHEMBL1592863 0.86 ALDH1A1 (0.71) ALDH1A1KEAP1TSHRMEN1KMT2A
SCHEMBL2240809 0.86 ALDH1A1 (0.71) ALDH1A1KEAP1TSHRMEN1KMT2A
SCHEMBL7562043 0.86 ALDH1A1 (1.00) ALDH1A1KEAP1TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140128352-A1 COMPOUNDS AND METHODS FOR MODULATING MITOCHONDRIAL METABOLISM AND REACTIVE OXYGEN SPECIES PRODUCTION BUCK INSTITUTE FOR RESEARCH ON AGING (US) 2014-05-08 US disclosed
US-20120149673-A1 INHIBITORS OF STORE OPERATED CALCIUM RELEASE CALCIMEDICA, INC. (US) 2012-06-14 US disclosed
US-20120149673-A1 INHIBITORS OF STORE OPERATED CALCIUM RELEASE CALCIMEDICA, INC. (US) 2012-06-14 US disclosed
US-8143269-B2 Inhibitors of store operated calcium release CALCIMEDICA, INC. (US) 2012-03-27 US disclosed
US-8143269-B2 Inhibitors of store operated calcium release CALCIMEDICA, INC. (US) 2012-03-27 US disclosed
US-20100087415-A1 INHIBITORS OF STORE OPERATED CALCIUM RELEASE CALCIMEDICA, INC. (US) 2010-04-08 US disclosed
US-20100087415-A1 INHIBITORS OF STORE OPERATED CALCIUM RELEASE CALCIMEDICA, INC. (US) 2010-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149673-A1 INHIBITORS OF STORE OPERATED CALCIUM RELEASE ORAI1, SARAF, RYR2 ALDH1A1 4125/4885KEAP1 2723/4885TSHR 4005/4885
US-20100087415-A1 INHIBITORS OF STORE OPERATED CALCIUM RELEASE ORAI1, SARAF, RYR2 ALDH1A1 4125/4885KEAP1 2723/4885TSHR 4005/4885
US-20140128352-A1 COMPOUNDS AND METHODS FOR MODULATING MITOCHONDRIAL METABOLISM AND REACTIVE OXYGEN SPECIES PRODUCTION PC, PCK2, TXNRD2 ALDH1A1 594/4885KEAP1 365/4885TSHR 2668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.